Saturday, June 23, 2007
The Science of Taking Life Industry
The connection between current "life science" corporations and warfare should be fairly well known, DuPont
- now major companies involved in seed production and agri-chemicals. Well, that history isn't over. According to a recent editorial
, the work of many "life science" companies in the arena of biowarfare research isn't being made public, despite legal requirements for NIH funded research.
Some of the companies in question: Abbott Laboratories, BASF Plant Science, Bristol-Myers Squibb, DuPont Central Research and Development, Eli Lilly Corp., Embrex, GlaxoSmithKline, Hoffman-LaRoche, Merck & Co., Monsanto, Pfizer Inc., Schering-Plough Research Institute, and Syngenta Corp. of Switzerland.
Quoting Sunshine Project
reports and University of Illinois, Urbana-Champaign international law scholar Francis Boyle, the editorial drops the following info:
- The Bush Administration has called for $44 billion for biowarfare research, apparently this is more than in any other time in history
- Only 8,500 (16%) of the 52,000 workers at the top 20 US biotech firms work as NIH guidelines-compliant facilities
- the Pentagon's Chemical and Biological Defense Program has been revised (as of 2003) to include offensive strikes
- the NIH received $1.76 billion for biodefense (mostly for anthrax research), while it only received $120 million to combat influenza, which kills around 36,000 US citizens annually.